A joint effort to give everyone the right to sight

Article

Forty five millon people are blind worldwide, yet 80% of blindness is avoidable

VISION 2020 member organisations are working together to eliminate avoidable blindness worldwide by the year 2020, in order to give everyone in the world the Right to Sight. As one corporate member, Carl Zeiss is working to make this vision a reality by helping people help themselves.

For example, we have committed ourselves to setting up ophthalmology training centres in five different regions of the world within five years. The first one was opened in Bandung, Indonesia in 2007. To equip this centre and train staff, we provided financial resources, slit lamps, therapeutic lasers and a surgical microscope. Together with the International Agency for Prevention of Blindness, we have coordinated training programmes.

In addition to these training centres, Carl Zeiss has also successfully partnered VISION 2020 in other initiatives. These include skills development and transfer and in equipping and upgrading existing training centres, in India, Africa and other parts of the developing world.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.